Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Arizona
Columbia University
Massachusetts General Hospital
OHSU Knight Cancer Institute
University of Chicago
University of Miami